Globe Life (GL) Financials

$121.18 -1.01 (-0.83%)

As of 11:22 AM Eastern

Annual Income Statements for Globe Life

This table shows Globe Life's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	1,071	971	894	1,031	732	761	701	1,454	550	527
Consolidated Net Income / (Loss)	1,071	971	894	1,031	732	761	701	1,454	550	527
Net Income / (Loss) Continuing Operations	1,071	971	894	1,031	732	761	702	1,458	540	516
Total Pre-Tax Income	1,327	1,194	1,102	1,275	897	931	864	831	772	766
Total Operating Income	1,454	1,297	1,193	1,358	983	1,016	954	-2,368	856	2,217
Total Gross Profit	2,884	2,583	2,401	2,453	2,165	2,170	2,029	-1,355	1,806	3,124
Total Revenue	5,778	5,448	5,227	5,112	4,738	4,528	4,304	873	3,935	3,766
Operating Revenue	5,778	5,448	5,227	5,112	4,738	4,528	4,304	871	3,935	3,766
Total Cost of Revenue	2,894	2,864	2,825	2,659	2,573	2,357	2,275	2,228	2,129	642
Operating Cost of Revenue	2,894	2,864	2,825	2,659	2,573	2,357	2,275	2,228	2,129	642
Total Operating Expenses	1,430	1,287	1,209	1,095	1,182	1,155	1,075	1,013	950	907
Selling, General & Admin Expense	419	348	354	322	301	305	280	257	232	224
Amortization Expense	410	380	349	318	576	552	517	490	469	446
Other Operating Expenses / (Income)	601	559	506	455	305	298	278	265	249	238
Total Other Income / (Expense), net	-127	-102	-90	-83	-87	-84	-90	3,198	-83	-1,451
Interest Expense	127	102	90	83	87	84	90	85	83	77
Income Tax Expense	256	224	208	243	165	170	162	-628	233	250
Basic Earnings per Share	$11.99	$10.21	$9.13	$10.10	$6.90	$6.97	$6.22	$12.50	$4.58	$4.21
Weighted Average Basic Shares Outstanding	83.85M	93.71M	96.50M	99.34M	103.28M	107.53M	110.24M	114.08M	117.76M	121.26M
Diluted Earnings per Share	$11.94	$10.07	$9.04	$9.99	$6.82	$6.83	$6.09	$12.22	$4.49	$4.16
Weighted Average Diluted Shares Outstanding	83.85M	93.71M	96.50M	99.34M	103.28M	107.53M	110.24M	114.08M	117.76M	121.26M
Weighted Average Basic & Diluted Shares Outstanding	83.85M	93.71M	96.50M	99.34M	103.28M	107.53M	110.24M	114.08M	117.76M	121.26M
Cash Dividends to Common per Share	$0.96	$0.90	$0.83	$0.79	$0.75	$0.69	$0.64	$0.60	$0.56	$0.54

This table shows Globe Life's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	255	255	303	258	254	275	257	215	224	242	191
Consolidated Net Income / (Loss)	255	255	303	258	254	275	257	215	224	242	191
Net Income / (Loss) Continuing Operations	255	255	303	258	254	275	257	215	224	242	191
Total Pre-Tax Income	316	312	377	322	315	337	319	265	274	297	235
Total Operating Income	351	348	408	354	344	362	345	290	299	1,401	-821
Total Gross Profit	730	728	767	705	684	696	665	609	613	1,712	-520
Total Revenue	1,480	1,466	1,455	1,440	1,416	1,416	1,384	1,326	1,321	2,414	218
Operating Revenue	1,480	1,466	1,455	1,440	1,416	1,416	1,384	1,326	1,321	2,415	218
Total Cost of Revenue	751	739	688	736	732	720	719	718	708	702	738
Operating Cost of Revenue	751	739	688	736	732	720	719	718	708	702	738
Total Operating Expenses	379	379	359	351	341	334	320	319	314	311	301
Selling, General & Admin Expense	109	122	105	99	93	92	86	86	84	92	88
Amortization Expense	106	104	104	102	99	98	96	94	92	90	88
Other Operating Expenses / (Income)	164	153	150	150	148	144	139	138	138	130	125
Total Other Income / (Expense), net	-35	-36	-31	-31	-29	-26	-26	-26	-25	-1,104	1,055
Interest Expense	35	36	31	31	29	26	26	26	25	25	24
Income Tax Expense	62	57	74	64	61	62	62	49	51	54	44
Basic Earnings per Share	$3.05	$3.00	$3.45	$2.83	$2.71	$2.91	$2.72	$2.26	$2.32	$2.50	$1.96
Weighted Average Basic Shares Outstanding	82.54M	83.85M	83.95M	89.82M	92.27M	93.71M	94.12M	94.82M	95.55M	96.50M	97.27M
Diluted Earnings per Share	$3.01	$3.00	$3.44	$2.83	$2.67	$2.87	$2.68	$2.24	$2.28	$2.47	$1.94
Weighted Average Diluted Shares Outstanding	82.54M	83.85M	83.95M	89.82M	92.27M	93.71M	94.12M	94.82M	95.55M	96.50M	97.27M
Weighted Average Basic & Diluted Shares Outstanding	82.54M	83.85M	83.95M	89.82M	92.27M	93.71M	94.12M	94.82M	95.55M	96.50M	97.27M
Cash Dividends to Common per Share	$0.27	-	$0.24	$0.24	$0.24	-	$0.23	$0.23	$0.23	-	$0.21

This table details how cash moves in and out of Globe Life's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	62	11	0.40	-2.68	19	-45	-10	48	15	-4.64
Net Cash From Operating Activities	1,402	1,482	1,422	1,438	1,476	1,364	1,278	1,429	1,399	1,120
Net Cash From Continuing Operating Activities	1,457	1,526	1,455	1,469	1,476	1,347	1,276	1,351	1,227	1,122
Net Income / (Loss) Continuing Operations	1,071	971	894	1,031	732	761	702	1,458	540	516
Consolidated Net Income / (Loss)	1,071	971	894	1,031	732	761	701	1,454	550	527
Amortization Expense	410	380	349	318	576	552	517	490	469	446
Non-Cash Adjustments To Reconcile Net Income	-121	69	84	-59	47	-712	-28	72	41	-589
Changes in Operating Assets and Liabilities, net	97	107	127	180	122	746	87	-669	177	749
Net Cash From Investing Activities	-642	-926	-943	-913	-1,182	-809	-896	-927	-1,062	-633
Net Cash From Continuing Investing Activities	-696	-970	-976	-945	-1,182	-814	-896	-927	-1,062	-633
Purchase of Property, Plant & Equipment	-71	-50	-28	-38	-42	-42	-45	-20	-25	-37
Purchase of Investments	-2,044	-1,915	-1,780	-1,316	-1,567	-1,692	-1,185	-110	-1,568	-1,103
Sale and/or Maturity of Investments	1,462	1,037	858	471	442	919	376	560	578	568
Other Investing Activities, net	-43	-42	-25	-62	-16	0.03	-42	-1,356	-48	-62
Net Cash From Financing Activities	-716	-541	-492	-524	-274	-591	-392	-454	-320	-526
Net Cash From Continuing Financing Activities	-716	-541	-492	-524	-274	-591	-392	-454	-320	-526
Repayment of Debt	-379	-166	-155	-233	-427	-6.88	-357	-129	-260	0.00
Repurchase of Common Equity	-1,002	-511	-455	-541	-444	-460	-422	-413	-405	-419
Payment of Dividends	-85	-84	-81	-80	-78	-74	-71	-69	-67	-67
Issuance of Debt	1,001	203	204	325	700	-12	550	186	422	1.98
Issuance of Common Equity	52	114	107	70	48	83	36	61	61	36
Other Financing Activities, net	-302	-97	-113	-64	-73	-121	-127	-91	-72	-78
Effect of Exchange Rate Changes	17	-4.19	14	-3.39	-1.73	-	-	-	-1.70	34

This table details how cash moves in and out of Globe Life's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-364	1,100	-291	-180	-566	1,108	-281	-417	-400	1,069	-1,149
Net Cash From Operating Activities	432	337	341	374	351	391	287	327	477	372	357
Net Cash From Continuing Operating Activities	-265	2,562	-117	-989	0.00	2,667	-461	-370	-310	1,455	-
Net Income / (Loss) Continuing Operations	0.00	1,071	-	-	0.00	971	-	-	0.00	894	-
Non-Cash Adjustments To Reconcile Net Income	-265	985	-117	-	-	1,210	-461	-370	-310	-	-
Net Cash From Investing Activities	-240	181	-196	105	-732	-98	-418	-162	-248	-252	-283
Net Cash From Continuing Investing Activities	25	-979	-80	1,044	-681	-1,283	43	208	62	-285	-283
Purchase of Property, Plant & Equipment	-12	-15	-29	-18	-9.11	-13	-11	-17	-8.21	-8.16	-6.14
Purchase of Investments	-65	-1,579	-280	579	-763	-1,842	-91	2.21	16	-415	-489
Sale and/or Maturity of Investments	132	596	255	499	112	531	172	255	79	84	247
Other Investing Activities, net	-30	19	-25	-16	-21	42	-27	-32	-25	55	-35
Net Cash From Financing Activities	-124	-501	-95	-477	357	-272	137	-255	-152	-115	-170
Net Cash From Continuing Financing Activities	-124	-501	-95	-235	115	-272	137	-255	-152	-115	-170
Repayment of Debt	-193	-89	61	-357	5.30	34	-8.76	-	-	61	-61
Repurchase of Common Equity	-265	-52	-591	-336	-23	-145	-97	-90	-179	-119	-72
Payment of Dividends	-20	-20	-22	-23	-21	-21	-21	-21	-20	-20	-20
Issuance of Debt	254	67	415	-	-	-165	198	105	65	-46	-
Issuance of Common Equity	81	17	5.09	-	30	53	19	5.16	37	57	15
Other Financing Activities, net	17	-424	37	-39	124	-27	47	-62	-54	-47	-32

This table presents Globe Life's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	29,076	28,051	25,987	29,768	29,047	25,977	23,096	23,475	21,436	19,853
Total Current Assets	18,367	733	17,559	900	926	518	536	871	16,002	671
Cash & Equivalents	165	103	93	92	95	76	121	119	76	61
Short-Term Investments	17,510	-	16,877	320	357	-	-	361	15,541	265
Accounts Receivable	692	630	589	487	474	442	415	392	384	345
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	10,709	27,318	8,428	28,868	28,121	25,460	22,560	22,604	5,434	19,183
Long-Term Investments	2,332	19,445	1,591	22,689	22,345	19,847	17,119	17,607	562	14,289
Goodwill	490	482	482	482	442	442	442	442	442	442
Other Noncurrent Operating Assets	7,887	7,112	6,355	5,697	5,334	5,171	4,931	4,487	4,431	4,139
Total Liabilities & Shareholders' Equity	29,076	28,051	25,987	29,768	29,047	25,977	37,559	23,475	21,436	19,853
Total Liabilities	23,771	23,565	22,037	21,125	20,276	18,683	32,144	17,244	16,869	15,798
Total Current Liabilities	2,406	1,987	1,770	2,822	2,648	2,301	1,865	2,132	2,496	2,377
Short-Term Debt	415	486	449	480	255	299	308	328	264	490
Current Deferred Revenue	258	255	253	65	62	64	-	61	64	67
Current Deferred & Payable Income Tax Liabilities	731	495	435	1,765	1,834	1,477	1,048	1,312	1,744	1,451
Other Current Liabilities	1,001	752	633	512	497	462	509	431	97	369
Total Noncurrent Liabilities	21,365	21,578	20,268	18,303	17,628	16,382	30,279	15,111	14,373	13,421
Long-Term Debt	2,324	1,630	1,628	1,546	1,668	1,349	1,357	1,132	1,133	744
Other Noncurrent Operating Liabilities	19,041	19,948	18,640	16,757	15,960	15,033	28,870	13,929	13,240	12,626
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	5,306	4,487	3,950	8,643	8,771	7,294	5,415	6,231	4,567	4,056
Total Preferred & Common Equity	5,306	4,487	3,950	8,643	8,771	7,294	5,415	6,231	4,567	4,056
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	5,306	4,487	3,950	8,643	8,771	7,294	5,415	6,231	4,567	4,056
Common Stock	625	635	635	630	641	649	646	633	618	613
Retained Earnings	8,003	7,479	6,895	6,182	5,874	5,551	5,213	4,806	3,891	3,614
Treasury Stock	-1,292	-854	-790	-847	-773	-751	-763	-632	-519	-403
Accumulated Other Comprehensive Income / (Loss)	-2,030	-2,772	-2,790	2,678	3,029	1,845	319	1,424	578	232

This table presents Globe Life's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	29,705	29,076	29,557	28,299	28,571	28,051	26,166	26,708	26,860	25,987	24,839
Total Current Assets	924	18,367	19,506	18,724	19,232	733	17,331	18,049	18,327	17,559	916
Cash & Equivalents	232	165	135	88	84	103	86	75	172	93	86
Accounts Receivable	692	692	652	648	646	630	617	602	594	589	475
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	28,781	10,709	10,050	9,575	9,339	27,318	8,835	8,659	8,533	8,428	23,923
Long-Term Investments	19,584	2,332	2,294	1,994	1,893	19,445	1,695	1,644	1,645	1,591	17,518
Noncurrent Note & Lease Receivables	426	-	-	-	-	279	-	-	-	-	-
Goodwill	490	490	490	482	482	482	482	482	482	482	482
Other Noncurrent Operating Assets	8,281	7,887	7,266	7,099	6,964	7,112	6,659	6,533	6,406	6,355	5,923
Total Liabilities & Shareholders' Equity	29,705	29,076	29,557	28,299	28,571	28,051	26,166	26,708	26,860	25,987	24,839
Total Liabilities	24,280	23,771	24,918	23,071	23,531	23,565	21,543	22,728	23,014	22,037	20,477
Total Current Liabilities	2,568	2,406	2,322	2,536	2,555	1,987	1,985	1,628	1,845	1,770	1,588
Short-Term Debt	477	415	437	655	734	486	448	258	514	449	435
Current Deferred Revenue	274	258	265	270	270	255	261	267	272	253	64
Current Deferred & Payable Income Tax Liabilities	808	731	620	685	630	495	555	404	428	435	568
Other Current Liabilities	1,010	1,001	1,000	927	921	752	721	699	632	633	521
Total Noncurrent Liabilities	21,712	21,365	22,596	20,535	20,976	21,578	19,558	21,099	21,168	20,268	18,889
Long-Term Debt	2,325	2,324	2,324	1,630	1,630	1,630	1,799	1,798	1,628	1,628	1,628
Other Noncurrent Operating Liabilities	19,387	19,041	20,273	18,905	19,346	19,948	17,760	19,301	19,540	18,640	17,262
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	5,425	5,306	4,639	5,228	5,039	4,487	4,623	3,980	3,846	3,950	4,362
Total Preferred & Common Equity	5,425	5,306	4,639	5,228	5,039	4,487	4,623	3,980	3,846	3,950	4,362
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	5,425	5,306	4,639	5,228	5,039	4,487	4,623	3,980	3,846	3,950	4,362
Common Stock	621	625	645	636	629	635	649	641	634	635	650
Retained Earnings	8,225	8,003	8,225	7,943	7,707	7,479	7,520	7,286	7,093	6,895	6,633
Treasury Stock	-1,450	-1,292	-1,747	-1,162	-829	-854	-1,087	-	-919	-790	-1,110
Accumulated Other Comprehensive Income / (Loss)	-1,971	-2,030	-2,485	-2,190	-2,467	-2,772	-2,459	-2,944	-2,961	-2,790	-1,812

This table displays calculated financial ratios and metrics derived from Globe Life's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.07%	4.22%	2.24%	7.90%	4.65%	5.20%	393.19%	-77.82%	4.48%	4.03%
EBITDA Growth	11.18%	8.76%	-8.02%	7.48%	-0.52%	6.59%	4.61%	6.11%	-50.26%	3.29%
EBIT Growth	12.12%	8.73%	-12.19%	38.10%	-3.17%	6.48%	4.21%	6.97%	-61.42%	2.55%
NOPAT Growth	11.33%	8.91%	-11.92%	36.90%	-3.28%	7.11%	118.64%	-795.31%	-59.99%	2.68%
Net Income Growth	10.30%	8.54%	-13.26%	40.91%	-3.81%	8.46%	-51.77%	164.56%	4.30%	-2.92%
EPS Growth	18.57%	11.39%	-9.51%	46.48%	-0.15%	12.15%	-50.16%	172.16%	7.93%	1.71%
Operating Cash Flow Growth	-5.40%	4.24%	-1.08%	-2.62%	8.25%	6.75%	-10.60%	2.17%	24.88%	29.53%
Free Cash Flow Firm Growth	-87.08%	37.08%	-25.16%	-25.75%	115.00%	-185.52%	481.67%	-428.20%	-19.98%	-37.11%
Invested Capital Growth	7.60%	-3.28%	-0.82%	-2.73%	-10.21%	55.43%	-136.62%	-2.22%	-6.26%	-0.02%
Revenue Q/Q Growth	0.88%	-15.49%	27.18%	-26.55%	30.61%	27.20%	325.29%	-75.26%	-19.71%	25.47%
EBITDA Q/Q Growth	-0.40%	-38.08%	251.11%	-52.71%	2,707.81%	93.48%	215.90%	136.57%	-49.18%	14.99%
EBIT Q/Q Growth	-0.97%	-44.47%	4,002.61%	-53.89%	256.11%	246.20%	153.67%	750.63%	-60.06%	18.01%
NOPAT Q/Q Growth	-0.97%	-44.47%	4,003.38%	-54.31%	227.40%	182.85%	143.60%	-5,594.37%	-59.64%	18.21%
Net Income Q/Q Growth	-1.80%	3.46%	7.76%	33.69%	-17.53%	44.03%	-56.20%	158.53%	0.46%	-2.55%
EPS Q/Q Growth	1.10%	4.14%	8.52%	35.37%	0.00%	0.00%	0.00%	161.11%	0.90%	-1.65%
Operating Cash Flow Q/Q Growth	-3.74%	1.34%	-0.41%	-1.38%	0.00%	-2.38%	-0.22%	-5.52%	2.69%	-29.76%
Free Cash Flow Firm Q/Q Growth	-94.42%	-22.98%	289.77%	-52.43%	5,406.58%	-1,585.78%	725.19%	-580.61%	-51.12%	10.20%
Invested Capital Q/Q Growth	13.00%	-12.18%	-8.66%	-2.57%	-5.03%	-0.47%	-137.86%	5.17%	0.51%	-3.42%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.91%	47.42%	45.94%	47.98%	45.70%	47.93%	47.13%	-155.30%	45.90%	82.96%
EBITDA Margin	32.26%	30.77%	29.49%	32.78%	32.91%	34.62%	34.17%	161.07%	33.67%	70.71%
Operating Margin	25.16%	23.80%	22.82%	26.57%	20.76%	22.43%	22.16%	-271.33%	21.74%	58.88%
EBIT Margin	25.16%	23.80%	22.82%	26.57%	20.76%	22.43%	22.16%	104.88%	21.74%	58.88%
Profit (Net Income) Margin	18.53%	17.82%	17.11%	20.17%	15.45%	16.80%	16.30%	166.68%	13.97%	14.00%
Tax Burden Percent	80.71%	81.28%	81.15%	80.90%	81.61%	81.69%	81.22%	175.10%	71.19%	68.80%
Interest Burden Percent	91.26%	92.11%	92.42%	93.85%	91.18%	91.70%	90.56%	90.76%	90.26%	34.55%
Effective Tax Rate	19.29%	18.72%	18.85%	19.10%	18.39%	18.30%	18.78%	-75.56%	30.13%	32.62%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	21.87%	23.01%	14.21%	11.84%	9.11%	11.97%	12.05%	26.94%	12.75%	12.04%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	5.09%	4.80%	4.28%	4.62%	3.57%	4.14%	4.10%	4.08%	4.14%	11.05%
Return on Assets (ROA)	3.75%	3.59%	3.21%	3.51%	2.66%	3.10%	3.01%	6.48%	2.66%	2.63%
Return on Common Equity (ROCE)	21.87%	23.01%	14.21%	11.84%	9.11%	11.97%	12.05%	26.94%	12.75%	12.04%
Return on Equity Simple (ROE_SIMPLE)	20.18%	21.64%	22.65%	11.93%	8.34%	10.43%	12.95%	23.34%	12.04%	13.00%
Net Operating Profit after Tax (NOPAT)	1,173	1,054	968	1,099	803	830	775	-4,157	598	1,494
NOPAT Margin	20.31%	19.35%	18.52%	21.49%	16.94%	18.33%	18.00%	-476.34%	15.19%	39.68%
Net Nonoperating Expense Percent (NNEP)	-0.59%	-0.49%	-0.39%	-0.32%	-0.36%	-0.29%	-0.31%	35.74%	-0.34%	-6.93%
Return On Investment Capital (ROIC_SIMPLE)	14.58%	15.96%	16.06%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	50.09%	52.58%	54.06%	52.02%	54.30%	52.07%	52.87%	255.30%	54.10%	17.04%
SG&A Expenses to Revenue	7.25%	6.39%	6.77%	6.30%	6.35%	6.73%	6.50%	29.48%	5.90%	5.94%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	24.75%	23.62%	23.13%	21.42%	24.94%	25.50%	24.97%	116.03%	24.15%	24.08%
Earnings before Interest and Taxes (EBIT)	1,454	1,297	1,193	1,358	983	1,016	954	915	856	2,217
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,864	1,676	1,541	1,676	1,559	1,567	1,470	1,406	1,325	2,663
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.76	2.52	2.91	1.08	1.10	1.51	1.47	1.60	1.81	1.62
Price to Tangible Book Value (P/TBV)	1.94	2.83	3.32	1.14	1.16	1.61	1.60	1.72	2.00	1.82
Price to Revenue (P/Rev)	1.62	2.08	2.20	1.82	2.04	2.43	1.85	11.41	2.10	1.75
Price to Earnings (P/E)	8.72	11.67	12.86	9.02	13.23	14.46	11.35	6.84	15.01	12.49
Dividend Yield	0.85%	0.73%	0.69%	0.85%	0.79%	0.67%	0.88%	0.68%	0.80%	1.00%
Earnings Yield	11.46%	8.57%	7.78%	11.09%	7.56%	6.92%	8.81%	14.61%	6.66%	8.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.52	0.47	0.53	0.23	0.22	0.23	0.31	0.23	0.31	0.30
Long-Term Debt to Equity	0.44	0.36	0.41	0.18	0.19	0.18	0.25	0.18	0.25	0.18
Financial Leverage	-3.54	-4.02	-2.98	-2.41	-2.44	-3.80	-4.01	-2.91	-3.29	-3.19
Leverage Ratio	5.83	6.41	4.43	3.38	3.43	3.86	4.00	4.16	4.79	4.58
Compound Leverage Factor	5.32	5.90	4.09	3.17	3.12	3.54	3.62	3.77	4.32	1.58
Debt to Total Capital	34.05%	32.04%	34.46%	18.99%	17.98%	18.43%	23.52%	18.99%	23.43%	23.33%
Short-Term Debt to Total Capital	5.16%	7.36%	7.45%	4.50%	2.38%	3.34%	4.35%	4.27%	4.43%	9.27%
Long-Term Debt to Total Capital	28.89%	24.68%	27.01%	14.50%	15.60%	15.09%	19.17%	14.72%	19.00%	14.06%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	65.95%	67.96%	65.54%	81.01%	82.02%	81.57%	76.48%	81.02%	76.57%	76.67%
Debt to EBITDA	1.47	1.26	1.35	1.21	1.23	1.05	1.13	1.04	1.06	0.46
Net Debt to EBITDA	-9.26	-10.40	-10.69	-12.58	-13.39	-11.66	-10.59	-11.83	-11.16	-5.02
Long-Term Debt to EBITDA	1.25	0.97	1.06	0.92	1.07	0.86	0.92	0.81	0.86	0.28
Debt to NOPAT	2.33	2.01	2.15	1.84	2.40	1.99	2.15	-0.35	2.34	0.83
Net Debt to NOPAT	-14.72	-16.54	-17.03	-19.18	-26.01	-22.03	-20.10	4.00	-24.73	-8.96
Long-Term Debt to NOPAT	1.98	1.55	1.68	1.41	2.08	1.63	1.75	-0.27	1.90	0.50
Altman Z-Score	1.64	0.95	1.77	0.80	0.77	0.87	0.72	0.73	1.62	0.96
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	7.63	0.37	9.92	0.32	0.35	0.22	0.29	0.41	6.41	0.28
Quick Ratio	7.63	0.37	9.92	0.32	0.35	0.22	0.29	0.41	6.41	0.28
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	189	1,466	1,069	1,429	1,924	-12,829	15,001	-3,930	1,198	1,497
Operating Cash Flow to CapEx	1,974.02%	2,991.59%	5,092.18%	3,759.23%	3,535.86%	3,231.70%	2,833.42%	7,051.16%	5,578.77%	3,030.68%
Free Cash Flow to Firm to Interest Expense	1.49	14.32	11.83	17.11	22.19	-152.17	166.54	-46.50	14.37	19.53
Operating Cash Flow to Interest Expense	11.03	14.49	15.73	17.22	17.03	16.18	14.18	16.91	16.78	14.61
Operating Cash Flow Less CapEx to Interest Expense	10.48	14.00	15.42	16.76	16.55	15.68	13.68	16.67	16.48	14.13
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.20	0.20	0.19	0.17	0.17	0.18	0.18	0.04	0.19	0.19
Accounts Receivable Turnover	8.74	8.93	9.71	10.63	10.35	10.57	10.67	2.25	10.79	11.20
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	41.76	40.85	37.59	34.33	35.28	34.54	34.22	162.34	33.81	32.58
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	41.76	40.85	37.59	34.33	35.28	34.54	34.22	162.34	33.81	32.58
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-11,962	-12,946	-12,534	-12,433	-12,103	-10,981	-24,640	-10,413	-10,187	-9,587
Invested Capital Turnover	-0.46	-0.43	-0.42	-0.42	-0.41	-0.25	-0.25	-0.08	-0.40	-0.39
Increase / (Decrease) in Invested Capital	984	-412	-101	-330	-1,121	13,659	-14,227	-226	-600	-2.33
Enterprise Value (EV)	-7,926	-6,106	-4,981	-11,780	-11,192	-7,277	-7,615	-6,673	-6,527	-6,795
Market Capitalization	9,341	11,327	11,502	9,296	9,682	10,999	7,959	9,953	8,254	6,586
Book Value per Share	$63.20	$47.67	$40.60	$85.59	$83.80	$67.36	$48.55	$53.98	$38.49	$32.88
Tangible Book Value per Share	$57.36	$42.55	$35.65	$80.82	$79.58	$63.28	$44.59	$50.15	$34.77	$29.30
Total Capital	8,045	6,602	6,027	10,669	10,694	8,942	7,080	7,692	5,965	5,289
Total Debt	2,740	2,116	2,077	2,026	1,923	1,648	1,665	1,460	1,398	1,234
Total Long-Term Debt	2,324	1,630	1,628	1,546	1,668	1,349	1,357	1,132	1,133	744
Net Debt	-17,267	-17,432	-16,483	-21,075	-20,874	-18,275	-15,575	-16,626	-14,781	-13,381
Capital Expenditures (CapEx)	71	50	28	38	42	42	45	20	25	37
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1,298	-871	-731	-1,855	-1,919	-1,561	-1,142	-1,413	-1,848	-1,542
Debt-free Net Working Capital (DFNWC)	16,377	-768	16,238	-1,442	-1,467	-1,485	-1,021	-933	13,770	-1,216
Net Working Capital (NWC)	15,961	-1,254	15,789	-1,922	-1,722	-1,783	-1,329	-1,262	13,505	-1,706
Net Nonoperating Expense (NNE)	103	83	73	68	71	69	73	-5,611	48	967
Net Nonoperating Obligations (NNO)	-17,267	-17,432	-16,483	-21,075	-20,874	-18,275	-30,055	-16,645	-14,754	-13,643
Total Depreciation and Amortization (D&A)	410	380	349	318	576	552	517	490	469	446
Debt-free, Cash-free Net Working Capital to Revenue	-22.47%	-15.99%	-13.99%	-36.29%	-40.50%	-34.47%	-26.54%	-161.88%	-46.96%	-40.95%
Debt-free Net Working Capital to Revenue	283.43%	-14.09%	310.68%	-28.21%	-30.97%	-32.79%	-23.72%	-106.97%	349.96%	-32.29%
Net Working Capital to Revenue	276.24%	-23.02%	302.08%	-37.60%	-36.35%	-39.39%	-30.88%	-144.57%	343.24%	-45.31%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$11.99	$10.21	$7.55	$7.30	$6.90	$6.97	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	83.85M	93.71M	96.50M	99.34M	103.28M	107.53M	0.00	0.00	0.00	0.00
Adjusted Diluted Earnings per Share	$11.94	$10.07	$7.47	$7.22	$6.82	$6.83	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	83.85M	93.71M	96.50M	99.34M	103.28M	107.53M	0.00	0.00	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	83.85M	93.71M	96.50M	99.34M	103.28M	107.53M	0.00	0.00	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	1,173	1,054	968	1,099	803	830	775	-1,657	598	1,494
Normalized NOPAT Margin	20.31%	19.35%	18.52%	21.49%	16.94%	18.33%	18.00%	-189.93%	15.19%	39.68%
Pre Tax Income Margin	22.96%	21.92%	21.09%	24.93%	18.93%	20.57%	20.07%	95.19%	19.63%	20.34%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	11.44	12.67	13.19	16.27	11.34	12.05	10.59	10.83	10.27	28.93
NOPAT to Interest Expense	9.23	10.30	10.71	13.16	9.26	9.84	8.60	-49.17	7.17	19.50
EBIT Less CapEx to Interest Expense	10.88	12.19	12.88	15.81	10.86	11.55	10.09	10.59	9.96	28.45
NOPAT Less CapEx to Interest Expense	8.67	9.82	10.40	12.70	8.77	9.34	8.10	-49.41	6.87	19.01
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	7.98%	8.67%	9.01%	7.76%	10.69%	9.75%	10.18%	4.73%	12.17%	12.69%
Augmented Payout Ratio	101.57%	61.31%	59.84%	60.27%	71.34%	70.16%	70.31%	33.13%	85.80%	92.09%

This table displays calculated financial ratios and metrics derived from Globe Life's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.54%	3.57%	5.15%	8.58%	7.18%	-41.36%	535.05%	2.68%	1.43%	86.22%	-82.94%
EBITDA Growth	3.06%	-1.63%	16.37%	18.53%	13.18%	-69.15%	27.04%	-0.02%	-1.80%	220.98%	-14.02%
EBIT Growth	2.19%	-3.94%	18.44%	21.84%	14.86%	-74.13%	33.25%	-2.67%	-4.78%	133.66%	2.81%
NOPAT Growth	1.96%	-3.86%	18.06%	20.00%	13.71%	-74.15%	141.74%	-2.23%	-3.82%	138.41%	-423.41%
Net Income Growth	0.14%	-7.13%	17.86%	20.02%	13.69%	13.39%	34.89%	-3.89%	-5.84%	-47.78%	0.91%
EPS Growth	12.73%	4.53%	28.36%	26.34%	17.11%	16.19%	38.14%	-0.89%	-3.80%	-45.47%	5.43%
Operating Cash Flow Growth	23.11%	-13.92%	18.72%	14.48%	-26.51%	5.27%	-19.64%	10.31%	20.19%	-1.55%	-0.28%
Free Cash Flow Firm Growth	-3,229.98%	-198.91%	796.96%	-114.10%	-102.44%	-43.20%	122.58%	13,795.88%	128.38%	53.79%	-255.74%
Invested Capital Growth	11.37%	7.60%	-19.15%	3.81%	2.34%	-3.28%	-0.04%	-10.84%	-10.17%	-0.82%	4.84%
Revenue Q/Q Growth	0.96%	0.75%	1.05%	1.70%	0.03%	2.28%	4.35%	0.39%	-45.27%	1,007.75%	-83.13%
EBITDA Q/Q Growth	0.92%	-11.75%	12.51%	2.85%	-3.68%	4.40%	14.60%	-1.79%	-73.74%	329.93%	-9.81%
EBIT Q/Q Growth	0.85%	-14.75%	15.44%	2.96%	-5.20%	5.11%	18.75%	-2.93%	-78.65%	441.33%	-13.25%
NOPAT Q/Q Growth	-0.56%	-13.37%	15.76%	2.24%	-6.23%	6.38%	17.67%	-3.12%	-78.68%	271.75%	-375.64%
Net Income Q/Q Growth	-0.25%	-15.78%	17.28%	1.63%	-7.49%	6.89%	19.43%	-3.73%	-7.73%	27.16%	-14.91%
EPS Q/Q Growth	0.33%	-12.79%	21.55%	5.99%	-6.97%	7.09%	19.64%	-1.75%	-7.69%	27.32%	-14.16%
Operating Cash Flow Q/Q Growth	28.18%	-1.08%	-8.96%	6.65%	-10.37%	36.43%	-12.22%	-31.53%	28.38%	4.15%	20.50%
Free Cash Flow Firm Q/Q Growth	-72.11%	-127.57%	1,289.25%	-490.10%	-102.88%	150.03%	-81.30%	2.23%	18.87%	199.39%	-11,240.29%
Invested Capital Q/Q Growth	3.12%	13.00%	-9.49%	3.96%	3.11%	-12.18%	11.60%	2.50%	-6.82%	-8.66%	2.06%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.29%	49.62%	52.72%	48.92%	48.32%	49.16%	48.05%	45.91%	46.42%	70.91%	-238.41%
EBITDA Margin	30.84%	30.85%	35.22%	31.64%	31.28%	32.49%	31.83%	28.98%	29.62%	61.75%	159.09%
Operating Margin	23.71%	23.74%	28.06%	24.56%	24.26%	25.60%	24.91%	21.89%	22.64%	58.01%	-376.47%
EBIT Margin	23.71%	23.74%	28.06%	24.56%	24.26%	25.60%	24.91%	21.89%	22.64%	58.01%	118.71%
Profit (Net Income) Margin	17.20%	17.40%	20.82%	17.94%	17.95%	19.41%	18.57%	16.23%	16.92%	10.04%	87.44%
Tax Burden Percent	80.54%	81.68%	80.38%	80.15%	80.72%	81.61%	80.64%	81.38%	81.54%	81.68%	81.18%
Interest Burden Percent	90.03%	89.75%	92.31%	91.12%	91.67%	92.91%	92.47%	91.11%	91.69%	21.18%	90.74%
Effective Tax Rate	19.46%	18.32%	19.62%	19.85%	19.28%	18.39%	19.36%	18.62%	18.46%	18.32%	18.82%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	20.47%	21.87%	23.55%	22.69%	22.54%	23.01%	20.89%	18.74%	16.40%	14.21%	12.80%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	4.75%	4.80%	5.77%	5.05%	4.85%	5.16%	6.30%	4.38%	4.34%	10.88%	17.96%
Return on Assets (ROA)	3.45%	3.52%	4.28%	3.69%	3.59%	3.91%	4.69%	3.25%	3.25%	1.88%	13.23%
Return on Common Equity (ROCE)	20.47%	21.87%	23.55%	22.69%	22.54%	23.01%	20.89%	18.74%	16.40%	14.21%	12.80%
Return on Equity Simple (ROE_SIMPLE)	19.74%	0.00%	23.51%	19.98%	19.87%	0.00%	20.30%	21.90%	22.89%	0.00%	19.03%
Net Operating Profit after Tax (NOPAT)	283	284	328	284	277	296	278	236	244	1,144	-666
NOPAT Margin	19.10%	19.39%	22.55%	19.69%	19.58%	20.89%	20.09%	17.81%	18.46%	47.38%	-305.61%
Net Nonoperating Expense Percent (NNEP)	-0.16%	-0.17%	-0.15%	-0.14%	-0.13%	-0.12%	-0.13%	-0.12%	-0.11%	-4.80%	4.68%
Return On Investment Capital (ROIC_SIMPLE)	3.44%	3.53%	-	-	-	4.48%	-	-	-	18.98%	-
Cost of Revenue to Revenue	50.71%	50.38%	47.28%	51.08%	51.68%	50.84%	51.95%	54.09%	53.58%	29.09%	338.41%
SG&A Expenses to Revenue	7.35%	8.32%	7.21%	6.88%	6.58%	6.48%	6.20%	6.49%	6.37%	3.80%	40.44%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	25.57%	25.87%	24.66%	24.36%	24.07%	23.56%	23.14%	24.02%	23.79%	12.90%	138.07%
Earnings before Interest and Taxes (EBIT)	351	348	408	354	344	362	345	290	299	1,401	259
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	457	452	513	456	443	460	441	384	391	1,491	347
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.03	1.76	2.05	1.45	2.16	2.52	2.21	2.60	2.74	2.91	2.20
Price to Tangible Book Value (P/TBV)	2.23	1.94	2.29	1.60	2.39	2.83	2.46	2.96	3.13	3.32	2.47
Price to Revenue (P/Rev)	1.89	1.62	1.66	1.34	1.96	2.08	1.58	1.96	2.01	2.20	2.34
Price to Earnings (P/E)	10.29	8.72	8.70	7.25	10.87	11.67	10.86	11.88	11.96	12.86	11.57
Dividend Yield	0.73%	0.85%	0.88%	1.12%	0.78%	0.73%	0.80%	0.78%	0.78%	0.69%	0.82%
Earnings Yield	9.72%	11.46%	11.49%	13.80%	9.20%	8.57%	9.20%	8.42%	8.36%	7.78%	8.64%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.52	0.52	0.60	0.44	0.47	0.47	0.49	0.52	0.56	0.53	0.47
Long-Term Debt to Equity	0.43	0.44	0.50	0.31	0.32	0.36	0.39	0.45	0.42	0.41	0.37
Financial Leverage	-3.36	-3.54	-3.73	-3.78	-3.98	-4.02	-3.57	-3.67	-3.38	-2.98	-2.82
Leverage Ratio	5.57	5.83	6.02	5.97	6.24	6.41	5.68	5.67	5.09	4.43	4.19
Compound Leverage Factor	5.01	5.24	5.55	5.44	5.72	5.95	5.25	5.17	4.67	0.94	3.80
Debt to Total Capital	34.06%	34.05%	37.31%	30.42%	31.93%	32.04%	32.70%	34.06%	35.78%	34.46%	32.10%
Short-Term Debt to Total Capital	5.80%	5.16%	5.91%	8.71%	9.91%	7.36%	6.52%	4.28%	8.59%	7.45%	6.77%
Long-Term Debt to Total Capital	28.26%	28.89%	31.40%	21.70%	22.02%	24.68%	26.18%	29.79%	27.19%	27.01%	25.34%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	65.94%	65.95%	62.69%	69.59%	68.07%	67.96%	67.30%	65.94%	64.22%	65.54%	67.90%
Debt to EBITDA	1.49	1.47	1.48	1.27	1.37	1.26	0.83	1.34	1.40	1.35	4.70
Net Debt to EBITDA	-9.06	-9.26	-9.83	-9.89	-10.48	-10.40	-5.97	-11.10	-11.23	-10.69	-36.21
Long-Term Debt to EBITDA	1.24	1.25	1.24	0.91	0.94	0.97	0.66	1.17	1.06	1.06	3.71
Debt to NOPAT	2.38	2.33	2.33	2.01	2.17	2.01	1.18	2.16	2.24	2.15	87.44
Net Debt to NOPAT	-14.43	-14.72	-15.52	-15.67	-16.66	-16.54	-8.52	-17.88	-17.99	-17.03	-674.03
Long-Term Debt to NOPAT	1.97	1.98	1.96	1.44	1.50	1.55	0.95	1.89	1.70	1.68	69.01
Altman Z-Score	0.83	1.52	1.56	1.52	1.59	0.84	1.68	1.63	1.61	1.79	0.82
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.36	7.63	8.40	7.38	7.53	0.37	8.73	11.09	9.93	9.92	0.58
Quick Ratio	0.36	7.63	8.40	7.38	7.53	0.37	8.73	11.09	9.93	9.92	0.58
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,204	-700	2,538	-213	-36	707	283	1,513	1,480	1,245	-1,253
Operating Cash Flow to CapEx	3,676.89%	2,246.48%	1,162.07%	2,121.81%	3,852.47%	2,986.85%	2,651.45%	1,876.18%	5,814.01%	4,554.78%	5,815.23%
Free Cash Flow to Firm to Interest Expense	-34.41	-19.61	80.85	-6.80	-1.26	27.55	10.90	58.61	59.53	50.51	-52.29
Operating Cash Flow to Interest Expense	12.34	9.44	10.85	11.91	12.26	15.24	11.05	12.66	19.20	15.08	14.90
Operating Cash Flow Less CapEx to Interest Expense	12.01	9.02	9.92	11.35	11.94	14.73	10.64	11.98	18.87	14.75	14.64
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.20	0.20	0.21	0.21	0.20	0.20	0.25	0.20	0.19	0.19	0.15
Accounts Receivable Turnover	8.74	8.74	9.03	9.05	8.94	8.93	11.80	9.77	9.69	9.71	8.55
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	41.78	41.76	40.43	40.33	40.84	40.85	30.92	37.34	37.66	37.59	42.67
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	41.78	41.76	40.43	40.33	40.84	40.85	30.92	37.34	37.66	37.59	42.67
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-11,589	-11,962	-13,749	-12,557	-13,076	-12,946	-11,540	-13,054	-13,389	-12,534	-11,535
Invested Capital Turnover	-0.47	-0.46	-0.45	-0.44	-0.42	-0.43	-0.56	-0.43	-0.41	-0.42	-0.35
Increase / (Decrease) in Invested Capital	1,487	984	-2,210	497	313	-412	-4.92	-1,277	-1,236	-101	587
Enterprise Value (EV)	-5,992	-7,926	-8,897	-10,215	-7,234	-6,106	-5,969	-6,675	-6,705	-4,981	-6,295
Market Capitalization	11,022	9,341	9,491	7,570	10,881	11,327	10,194	10,360	10,531	11,502	9,602
Book Value per Share	$64.71	$63.20	$51.64	$56.66	$53.78	$47.67	$48.76	$41.65	$39.86	$40.60	$44.76
Tangible Book Value per Share	$58.86	$57.36	$46.18	$51.44	$48.63	$42.55	$43.68	$36.61	$34.87	$35.65	$39.82
Total Capital	8,227	8,045	7,400	7,513	7,403	6,602	6,869	6,037	5,989	6,027	6,424
Total Debt	2,802	2,740	2,761	2,285	2,364	2,116	2,246	2,056	2,143	2,077	2,062
Total Long-Term Debt	2,325	2,324	2,324	1,630	1,630	1,630	1,799	1,798	1,628	1,628	1,628
Net Debt	-17,014	-17,267	-18,388	-17,785	-18,115	-17,432	-16,163	-17,035	-17,236	-16,483	-15,896
Capital Expenditures (CapEx)	12	15	29	18	9.11	13	11	17	8.21	8.16	6.14
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1,400	-1,298	-1,232	-1,233	-1,176	-871	-920	-768	-737	-731	-678
Debt-free Net Working Capital (DFNWC)	-1,168	16,377	17,622	16,843	17,410	-768	15,794	16,679	16,996	16,238	-237
Net Working Capital (NWC)	-1,645	15,961	17,185	16,188	16,676	-1,254	15,347	16,421	16,482	15,789	-672
Net Nonoperating Expense (NNE)	28	29	25	25	23	21	21	21	20	902	-857
Net Nonoperating Obligations (NNO)	-17,014	-17,267	-18,388	-17,785	-18,115	-17,432	-16,163	-17,035	-17,236	-16,483	-15,896
Total Depreciation and Amortization (D&A)	106	104	104	102	99	98	96	94	92	90	88
Debt-free, Cash-free Net Working Capital to Revenue	-23.96%	-22.47%	-21.52%	-21.80%	-21.21%	-15.99%	-14.27%	-14.55%	-14.04%	-13.99%	-16.50%
Debt-free Net Working Capital to Revenue	-19.99%	283.43%	307.68%	297.78%	314.13%	-14.09%	245.01%	315.89%	324.02%	310.68%	-5.78%
Net Working Capital to Revenue	-28.15%	276.24%	300.04%	286.20%	300.89%	-23.02%	238.07%	311.00%	314.21%	302.08%	-16.36%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.05	$3.00	$3.45	$2.83	$2.71	$2.91	$2.72	$2.26	$2.32	$2.50	$1.92
Adjusted Weighted Average Basic Shares Outstanding	82.54M	83.85M	83.95M	89.82M	92.27M	93.71M	94.12M	94.82M	95.55M	96.50M	97.27M
Adjusted Diluted Earnings per Share	$3.01	$3.00	$3.44	$2.83	$2.67	$2.87	$2.68	$2.24	$2.28	$2.47	$1.90
Adjusted Weighted Average Diluted Shares Outstanding	82.54M	83.85M	83.95M	89.82M	92.27M	93.71M	94.12M	94.82M	95.55M	96.50M	97.27M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	82.54M	83.85M	83.95M	89.82M	92.27M	93.71M	94.12M	94.82M	95.55M	96.50M	97.27M
Normalized Net Operating Profit after Tax (NOPAT)	283	284	328	284	277	296	278	236	244	1,144	-666
Normalized NOPAT Margin	19.10%	19.39%	22.55%	19.69%	19.58%	20.89%	20.09%	17.81%	18.46%	47.38%	-305.61%
Pre Tax Income Margin	21.35%	21.31%	25.90%	22.38%	22.24%	23.78%	23.03%	19.94%	20.75%	12.29%	107.72%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	10.03	9.76	13.01	11.26	12.00	14.11	13.28	11.25	12.03	56.80	10.80
NOPAT to Interest Expense	8.08	7.97	10.46	9.03	9.69	11.52	10.71	9.15	9.81	46.39	-27.79
EBIT Less CapEx to Interest Expense	9.70	9.34	12.08	10.70	11.69	13.60	12.87	10.57	11.70	56.47	10.54
NOPAT Less CapEx to Interest Expense	7.74	7.55	9.52	8.47	9.37	11.01	10.29	8.48	9.48	46.06	-28.05
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	7.89%	7.98%	7.93%	8.26%	8.50%	8.67%	8.85%	9.40%	9.19%	9.01%	9.69%
Augmented Payout Ratio	123.96%	101.57%	108.41%	65.84%	43.99%	61.31%	60.55%	62.19%	67.62%	59.84%	67.94%

Frequently Asked Questions About Globe Life's Financials

When does Globe Life's financial year end?

According to the most recent income statement we have on file, Globe Life's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Globe Life's net income changed over the last 9 years?

Globe Life's net income appears to be on an upward trend, with a most recent value of $1.07 billion in 2024, rising from $527.10 million in 2015. The previous period was $970.76 million in 2023. See where experts think Globe Life is headed by visiting Globe Life's forecast page.

What is Globe Life's operating income?

Globe Life's total operating income in 2024 was $1.45 billion, based on the following breakdown:

Total Gross Profit: $2.88 billion
Total Operating Expenses: $1.43 billion

How has Globe Life revenue changed over the last 9 years?

Over the last 9 years, Globe Life's total revenue changed from $3.77 billion in 2015 to $5.78 billion in 2024, a change of 53.4%.

How much debt does Globe Life have?

Globe Life's total liabilities were at $23.77 billion at the end of 2024, a 0.9% increase from 2023, and a 50.5% increase since 2015.

How much cash does Globe Life have?

In the past 9 years, Globe Life's cash and equivalents has ranged from $61.38 million in 2015 to $165.33 million in 2024, and is currently $165.33 million as of their latest financial filing in 2024.

How has Globe Life's book value per share changed over the last 9 years?

Over the last 9 years, Globe Life's book value per share changed from 32.88 in 2015 to 63.20 in 2024, a change of 92.2%.

Related Companies

This page (NYSE:GL) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Globe Life (GL) Financials

Frequently Asked Questions About Globe Life's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Globe Life (GL) Financials

Annual Income Statements for Globe Life

Quarterly Income Statements for Globe Life

Annual Cash Flow Statements for Globe Life

Quarterly Cash Flow Statements for Globe Life

Annual Balance Sheets for Globe Life

Quarterly Balance Sheets for Globe Life

Annual Metrics And Ratios for Globe Life

Quarterly Metrics And Ratios for Globe Life

Frequently Asked Questions About Globe Life's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools